US Patent 10428319 Engineered Cas9 nucleases
Patent 10428319 was granted and assigned to Editas Medicine on October, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 8, 2018
0
Date of Patent
October 1, 2019
0
Patent Applicant
Patent Application Number
16003967
0
Patent Citations Received
Patent Inventor Names
Derek Cerchione
0
Barrett Ethan Steinberg
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10428319 Engineered Cas9 nucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.